Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Inspire Medical Systems (NYSE: INSP) announced its management team will present at the 44th Annual J.P.

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 12:45 p.m. Eastern Time.

The presentation will be available via a live webcast, with a replay accessible for two weeks after the event in the Event Archive on Inspire’s investor website: https://investors.inspiresleep.com.

Argus Dec 29 session

-1.89% close to close Open Argus

Details

News Market Reaction – INSP

On Dec 29, the day this news came out, INSP closed 1.89% below the previous close.

Data tracked by StockTitan Argus for the Dec 29 session.

Market Context

This announcement highlights Inspire Medical Systems’ plan to present at the 44th Annual J.P. Morgan...

Analysis

This announcement highlights Inspire Medical Systems’ plan to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at 12:45 p.m. Eastern Time, with a live webcast and a replay available for two weeks. Investors may view this in the context of recent earnings, clinical data, and regulatory filings, focusing on any strategic updates or guidance commentary shared during the session and how they complement prior disclosures.

Key Figures

Conference date: January 12, 2026 Presentation time: 12:45 p.m. Eastern Time Replay window: Two weeks

Conference date

January 12, 2026

Scheduled J.P. Morgan Healthcare Conference presentation date

Presentation time

12:45 p.m. Eastern Time

Scheduled start time of the J.P. Morgan presentation

Replay window

Two weeks

Duration webcast replay will be available on investor website

Historical Context

5 past events · Latest: Nov 18

5 events

1. Nov 18

   Conference appearance

   24h Move

   -1.5%

   Announcement of Piper Sandler healthcare conference presentation and webcast access.

2. Nov 03

   Earnings results

   24h Move

   +2.3%

   Q3 2025 results with revenue growth, high gross margin, and raised EPS guidance.

3. Oct 27

   Conference appearance

   24h Move

   +0.9%

   UBS Global Healthcare Conference presentation and webcast details for investors.

4. Oct 10

   Clinical data update

   24h Move

   -6.2%

   Inspire V clinical data showing improved IPOP, shorter surgery, and AHI reductions.

5. Oct 06

   Earnings call timing

   24h Move

   -0.3%

   Scheduling of Q3 2025 earnings release and conference call logistics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

obstructive sleep apnea

1 terms

obstructive sleep apnea medical

"solutions for patients with obstructive sleep apnea, announced today that its"

Obstructive sleep apnea is a common medical condition where the throat repeatedly narrows or closes during sleep, causing short pauses in breathing, drops in blood oxygen and fragmented rest. It matters to investors because it creates ongoing demand for medical devices, diagnostics, treatments and sleep-monitoring services, and it can affect population health, workforce productivity and healthcare spending—like a recurring leak in a system that requires continual repair and monitoring.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44^th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.

Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Inspire Medical Systems (INSP) present at the J.P. Morgan Healthcare Conference?

Inspire will present on Monday, January 12, 2026 at 12:45 p.m. Eastern Time.

How can investors watch Inspire Medical Systems (INSP) present on January 12, 2026?

Investors can watch via the live webcast linked on Inspire’s investor site.

Will a replay of Inspire Medical Systems (INSP) presentation be available after January 12, 2026?

Yes. A webcast replay will be available for two weeks in the Event Archive on the investor website.

Where is the replay of the INSP J.P. Morgan presentation hosted?

The replay is hosted in the Event Archive at https://investors.inspiresleep.com.

What topics will Inspire (INSP) management cover at the J.P. Morgan conference?

The company said management will present recent developments and outlook; specific slides will be shown during the webcast.

Is the Inspire (INSP) J.P. Morgan webcast free to access for shareholders?

Yes. The live webcast and two-week replay are publicly accessible via Inspire’s investor website.